Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blinded, Randomized Controlled Trial of Simvastatin Use As Adjuvant Therapy in Relapsing-Remitting Multiple Sclerosis

NCT04178980 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04178980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04178980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blinded, Randomized Controlled Trial of Simvastatin Use As Adjuvant Therapy in Relapsing-Remitting Multiple Sclerosis
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Unknown status
Start date
January 1, 2020
Completion date
March 1, 2022
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

simvastatin multiple sclerosis